CI: financial statements from SEC — TradeAlmanac

The Cigna Group: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

Income statement

Metric	31 Dec 2025	31 Dec 2024
Revenue	274.90B	247.12B
Cost of revenue	214.99B	182.51B
Selling, general and administrative	14.62B	14.84B
Operating income	9.20B	9.42B
Pre-tax income	7.78B	5.27B
Income tax	1.49B	1.49B
Net income	5.96B	3.43B
Earnings per share	22.33	12.25
Earnings per share, diluted	22.18	12.12

Metric	31 Mar 2026	31 Dec 2025	30 Sept 2025	30 Jun 2025	31 Mar 2025	31 Dec 2024	30 Sept 2024	30 Jun 2024
Cash and equivalents	7.04B	7.68B	6.03B	4.33B	8.33B	7.55B	5.94B	6.83B
Short-term investments	812M	1.06B

Metric	31 Dec 2025	31 Dec 2024
Operating cash flow	9.60B	10.36B
Depreciation and amortisation	2.78B	2.78B
Investing cash flow	−4.41B	−2.10B
Dividends paid	1.61B	1.57B
Share buybacks	3.62B	7.03B
Financing cash flow	−6.42B

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator